Lataa...
Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives
Systemic immunoglobulin light chain (AL) amyloidosis is a disorder characterized by the production of clonal serum free light chains that misfold, aggregate, and deposit in vital organs. Treatment of this disease is typically targeted at the abnormal plasma cell clone in the bone marrow which is the...
Tallennettuna:
| Julkaisussa: | J Blood Med |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6815750/ https://ncbi.nlm.nih.gov/pubmed/31695543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S183857 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|